Biopharma Strategies Group Inc is categorized under Marketing Consultants in Chapel Hill, NC .
Biopharma Strategies Group Inc was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Marketing Consultants business, which does work in the B2B market, and is classified as a Marketing Consultants, under code number 5416130 by the NAICS.
If you are seeking more information, feel free to contact Leisa Dennehy, Owner at the company’s single location by writing to 121 South Estes Drive # 203f, Chapel Hill, North Carolina NC 27514 or by phoning (919) 933-7040. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Biopharma Strategies Group Inc |
Contact Person: | Leisa Dennehy, Owner |
Address: | 121 South Estes Drive # 203f, Chapel Hill, North Carolina 27514 |
Phone Number: | (919) 933-7040 |
Annual Revenue (USD): | $500.000 to $999.999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Marketing Consultants |
SIC Code: | 8742 |
NAICS Code: | 5416130 |
Share This Business: |
Biopharma Strategies Group Inc was started in 0 to provide professional Marketing Consultants under the SIC code 8742 and NAICS code 5416130. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Leisa Dennehy, Owner for inquiries that concern Biopharma Strategies Group Inc by calling the company number (919) 933-7040, as your correspondence is most welcome. Additionally, the physical location of the single location of Biopharma Strategies Group Inc can be found at the coordinates 35.930099,-79.036968 as well as the street address 121 South Estes Drive # 203f in Chapel Hill, North Carolina 27514.
For its online presence, you may visit Biopharma Strategies Group Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.